Unknown

Dataset Information

0

Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.


ABSTRACT: FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival signaling in tumor cells, we hypothesized that targeting a key protein-protein interface with druglike small molecules was a feasible strategy for inhibiting tumor growth. In this study, we targeted the protein-protein interface between FAK and VEGFR-3 and identified compound C4 (chloropyramine hydrochloride) as a drug capable of (1) inhibiting the biochemical function of VEGFR-3 and FAK, (2) inhibiting proliferation of a diverse set of cancer cell types in vitro, and (3) reducing tumor growth in vivo. Chloropyramine hydrochloride reduced tumor growth as a single agent, while concomitant administration with doxorubicin had a pronounced synergistic effect. Our data demonstrate that the FAK-VEGFR-3 interaction can be targeted by small druglike molecules and this interaction can provide the basis for highly specific novel cancer therapeutics.

SUBMITTER: Kurenova EV 

PROVIDER: S-EPMC2765121 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.

Kurenova Elena V EV   Hunt Darell L DL   He Dihua D   Magis Andrew T AT   Ostrov David A DA   Cance William G WG  

Journal of medicinal chemistry 20090801 15


FAK is a tyrosine kinase that functions as a key orchestrator of signals leading to invasion and metastasis. Since FAK interacts directly with a number of critical proteins involved in survival signaling in tumor cells, we hypothesized that targeting a key protein-protein interface with druglike small molecules was a feasible strategy for inhibiting tumor growth. In this study, we targeted the protein-protein interface between FAK and VEGFR-3 and identified compound C4 (chloropyramine hydrochlor  ...[more]

Similar Datasets

| S-EPMC6406613 | biostudies-literature
| S-EPMC3648504 | biostudies-literature
| S-EPMC2234176 | biostudies-literature
| S-EPMC2973011 | biostudies-literature
| S-EPMC5784113 | biostudies-literature
| S-EPMC7954604 | biostudies-literature
| S-EPMC2664169 | biostudies-literature
| S-EPMC8309178 | biostudies-literature
| S-EPMC2597516 | biostudies-literature
| S-EPMC3809027 | biostudies-literature